Souhaitez-vous accéder aux communiqués récents ?

Nashville, Tenn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- A new national survey released today by Qualifacts, the leading behavioral health technology partner specializing in AI-powered electronic health...

Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive symptoms as measured by MADRS score (mean difference:...

An evening at a beloved Filipino community restaurant blends live performance with a candid conversation on creativity and emotional growth

- Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events -- Topline data readout from the Phase 2 study evaluating HLP004 in generalized anxiety disorder...

BOSTON and OAK BROOK, Ill. and SACRAMENTO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- After rigorous deliberation, Eleos, the leader in AI for behavioral health, today announced that the California...

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior...

SEATTLE, Feb. 09, 2026 (GLOBE NEWSWIRE) -- mpathic, a clinician-founded AI safety company, today announced its expansion to support foundational model developers and LLM-powered application teams as...

Mental Wellness Month spotlights the search for lasting mental health solutions, with Dianetics offering a long-standing approach to understanding the mind

CHICAGO, IL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- As January marks Mental Wellness Month, experts at The Neurologic Wellness Institute are spotlighting neurofeedback therapy as an evidence-based...

InStride Health and The Wharton School collaborate on AI scribe case study, highlighting clinical and technical partnerships for responsible AI adoption.